Related content

Poor prognosis for ovarian response to stimulation: results of a randomised trial comparing the flare-up GnRH agonist protocol vs. the antagonist protocol

By Devesa Marta   Martínez Francisca   Coroleu Buenaventura   Tur Rosa   González Clara   Rodríguez Ignacio   Barri Pedro N.  

Gynecological Endocrinology, Vol. 26, Iss. 7, 2010-07 ,pp. : 509-515

Informa Healthcare

Access to resources Recommend Favorite

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial

By Cheung Lai-Ping   Lam Po-Mui   Lok Ingrid Hung   Chiu Tony Tak-Yu   Yeung Sum-Yee   Tjer Ching-Ching   Haines Christopher John  

Human Reproduction, Vol. 20, Iss. 3, 2005-03 ,pp. : 616-621

Oxford University Press

Access to resources Recommend Favorite

Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis

By Chen Ying   Zhang Yi   Hu Min   Liu Xiru   Qi Hongbo  

Gynecological Endocrinology, Vol. 30, Iss. 6, 2014-06 ,pp. : 431-437

Informa Healthcare

Access to resources Recommend Favorite

Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)

By Lainas Trifon G.   Sfontouris Ioannis A.   Zorzovilis Ioannis Z.   Petsas George K.   Lainas George T.   Alexopoulou Efthymia   Kolibianakis Efstratios M.  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 683-689

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Engmann Lawrence   Benadiva Claudio  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3258-3260

Oxford University Press

Access to resources Recommend Favorite